| Sep'18 | Dec'17 | Dec'16 | ||||
|---|---|---|---|---|---|---|
CURRENT ASSETS | ||||||
Cash and cash equivalents | ||||||
25,950 | 55,394 | 8,056 | ||||
Restricted cash | ||||||
833 | 833 | 833 | ||||
Receivables, prepaids and deposits | ||||||
1,750 | 1,017 | 979 | ||||
Deferred financing and transaction costs | ||||||
2,722 | 1,888 | - | ||||
Organoclay inventories | ||||||
1,394 | 2,086 | 531 | ||||
Total current assets | ||||||
32,649 | 61,218 | 10,399 | ||||
NON-CURRENT ASSETS | ||||||
Restricted cash | ||||||
150 | 983 | 1,817 | ||||
Loans to Joint Venture | ||||||
25,239 | 11,479 | - | ||||
Investment in Joint Venture | ||||||
29,811 | 19,637 | 13,136 | ||||
Property, plant and equipment | ||||||
17,488 | 18,070 | 18,502 | ||||
Exploration and evaluation assets | ||||||
2,768 | 2,104 | 1,447 | ||||
Total non-current assets | ||||||
75,456 | 52,273 | 34,902 | ||||
TOTAL ASSETS | ||||||
108,105 | 113,491 | 45,301 | ||||
CURRENT LIABILITIES | ||||||
Accounts payable and accrued liabilities | ||||||
3,572 | 3,546 | 1,637 | ||||
Current portion of long-term borrowings | ||||||
243 | 178 | 169 | ||||
Total current liabilities | ||||||
3,815 | 3,724 | 1,806 | ||||
LONG-TERM LIABILITIES | ||||||
Long-term borrowings | ||||||
10,553 | 751 | 902 | ||||
Decommissioning provision | ||||||
249 | 249 | 170 | ||||
Total long-term liabilities | ||||||
10,802 | 1,000 | 1,072 | ||||
TOTAL LIABILITIES | ||||||
14,617 | 4,724 | 2,878 | ||||
SHAREHOLDERS EQUITY | ||||||
Share capital | ||||||
197,918 | 197,390 | 108,670 | ||||
Contributed surplus | ||||||
25,392 | 20,812 | 11,948 | ||||
Accumulated other comprehensive loss | ||||||
-1,852 | -114 | -2,124 | ||||
Deficit | ||||||
-127,970 | -109,321 | -76,071 | ||||
TOTAL SHAREHOLDERS EQUITY | ||||||
93,488 | 108,767 | 42,423 | ||||
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | ||||||
108,105 | 113,491 | 45,301 | ||||